116 related articles for article (PubMed ID: 2733453)
1. TdT+/nonlymphoid antigen+ acute leukemias: immunologic and karyotypic monitoring during therapy and at relapse suggests the transformation of a bipotential stem cell.
Paietta E; Gucalp R; Papenhausen P; Dutcher JP; Wiernik PH
Leukemia; 1989 Jul; 3(7):485-91. PubMed ID: 2733453
[TBL] [Abstract][Full Text] [Related]
2. Detection of residual disease in AML patients by use of double immunological marker analysis for terminal deoxynucleotidyl transferase and myeloid markers.
Adriaansen HJ; Jacobs BC; Kappers-Klunne MC; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1993 Mar; 7(3):472-81. PubMed ID: 7680403
[TBL] [Abstract][Full Text] [Related]
3. Terminal deoxynucleotidyl transferase positive subpopulations occur in the majority of ANLL: implications for the detection of minimal disease.
Adriaansen HJ; van Dongen JJ; Kappers-Klunne MC; Hählen K; van 't Veer MB; Wijdenes-de Bresser JH; Holdrinet AC; Harthoorn-Lasthuizen EJ; Abels J; Hooijkaas H
Leukemia; 1990 Jun; 4(6):404-10. PubMed ID: 2359340
[TBL] [Abstract][Full Text] [Related]
4. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
5. The 5q-- deletion: correlation of breakpoints with the immunophenotype of leukemic blast cells.
Paietta E; Papenhausen P; Gucalp R; Reed J; Wiernik PH
Leukemia; 1987 Dec; 1(12):822-4. PubMed ID: 3695588
[TBL] [Abstract][Full Text] [Related]
6. Translocation (6;9) may be associated with a specific TdT-positive immunological phenotype in ANLL.
Adriaansen HJ; van Dongen JJ; Hooijkaas H; Hählen K; van 't Veer MB; Löwenberg B; Hagemeijer A
Leukemia; 1988 Mar; 2(3):136-40. PubMed ID: 3347092
[TBL] [Abstract][Full Text] [Related]
7. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and biological implications of acute mixed lineage (hybrid) leukemias.
Altman AJ
Am J Pediatr Hematol Oncol; 1990; 12(2):123-33. PubMed ID: 2198821
[TBL] [Abstract][Full Text] [Related]
9. Terminal transferase positive acute promyelocytic leukemia: in vitro differentiation of a T-lymphocytic/promyelocytic hybrid phenotype.
Paietta E; Dutcher JP; Wiernik PH
Blood; 1985 Jan; 65(1):107-14. PubMed ID: 3871159
[TBL] [Abstract][Full Text] [Related]
10. FISH monitoring of 100 courses of human leukemias: the cytogenetic viewpoint.
Gebhart E; Rösler W; Gramatzki M; Trautmann U
Int J Oncol; 2001 Sep; 19(3):617-23. PubMed ID: 11494045
[TBL] [Abstract][Full Text] [Related]
11. Terminal deoxynucleotidyl transferase (TdT) in acute nonlymphocytic leukemia. A clinical, morphologic, cytochemical, immunologic, and ultrastructural study.
McCurley TL; Greer JP; Glick AD
Am J Clin Pathol; 1988 Oct; 90(4):421-30. PubMed ID: 2459954
[TBL] [Abstract][Full Text] [Related]
12. The immunophenotype of blast transformation of chronic myelogenous leukemia: a high frequency of mixed lineage phenotype in "lymphoid" blasts and A comparison of morphologic, immunophenotypic, and molecular findings.
Khalidi HS; Brynes RK; Medeiros LJ; Chang KL; Slovak ML; Snyder DS; Arber DA
Mod Pathol; 1998 Dec; 11(12):1211-21. PubMed ID: 9872654
[TBL] [Abstract][Full Text] [Related]
13. [Phenotypic changes in refractory and relapse acute lymphoblastic leukemias].
Gómez E; San Miguel JF; González M; Orfao A; Cañizo MC; Ciudad J; López Borrasca A
Sangre (Barc); 1991 Jun; 36(3):201-4. PubMed ID: 1948539
[TBL] [Abstract][Full Text] [Related]
14. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
[TBL] [Abstract][Full Text] [Related]
15. Clinical and morphological features of cases of trisomy 13 in acute non-lymphocytic leukemia.
Soni M; Brody J; Allen SL; Schulman P; Kolitz J; Rai K; Broome JD; Koduru PR
Leukemia; 1996 Apr; 10(4):619-23. PubMed ID: 8618437
[TBL] [Abstract][Full Text] [Related]
16. Distinct antigen expression related to DNA ploidy in a case of biphenotypic leukemia.
Paietta E; Andreeff M; Papenhausen P; Gucalp R; Wiernik PH
Leukemia; 1989 Jan; 3(1):76-8. PubMed ID: 2909810
[TBL] [Abstract][Full Text] [Related]
17. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
18. Terminal transferase in leukemias by flow cytometry.
Loftin KC; Reuben JM; Dalton W; Hersh EM; Sujansky D
Diagn Immunol; 1986; 4(3):165-9. PubMed ID: 3460728
[TBL] [Abstract][Full Text] [Related]
19. Detection of terminal transferase in acute myeloid leukemia by flow cytometry.
Paietta E; Meenan B; Heavey C; Thomas D
Cytometry; 1994 Jul; 16(3):256-61. PubMed ID: 7924695
[TBL] [Abstract][Full Text] [Related]
20. CD56(+) TdT(+) blastic natural killer cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia.
Khoury JD; Medeiros LJ; Manning JT; Sulak LE; Bueso-Ramos C; Jones D
Cancer; 2002 May; 94(9):2401-8. PubMed ID: 12015765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
